Literature DB >> 1319116

Variability in the clinical and pathological findings in the neuronal ceroid lipofuscinoses: review of data and observations.

K E Wisneiwski1, E Kida, O F Patxot, F Connell.   

Abstract

We reviewed the clinical and pathological data on 319 neuronal ceroid lipofuscinosis (NCL) cases to determine the degree of variability within the different forms and among and within families. Thirty-six cases (11.3%) were the infantile form; 116 cases (36.3%), late infantile; 163 cases (51.1%), juvenile; and four cases (1.3%), the adult form (Kufs disease). Clinical variability was found in all forms studied, but was most striking in the juvenile and late infantile forms of NCL. The expected initial findings of seizures, dementia, blindness, or motor impairment were evident in 255 cases (80%), and rarer, less typical initial neurological symptoms were seen mainly in the 64 cases (20%) of the juvenile form: behavior abnormalities (18/64), psychoses (12/64), neuropathy (2/64), involuntary movements (15/64), ataxia (9/64). Six juvenile and two adult cases had no detectable impairment of vision. All 319 NCL cases had skin or conjunctive biopsies or buffy coats that showed the characteristic ultrastructural abnormalities of NCL. Variability was evident in 16.7% in that a combination of fingerprint, curvilinear, and membranous profile inclusion bodies was observed in storage lysosomes, although one type of inclusion was distinctly predominant for each form. Postmortem examination of brains of 19 NCL cases (three with the infantile form, six with the late infantile form, nine with the juvenile form, and one with the adult form) revealed characteristic changes. Sixteen of the 19 NCL brains (84%) showed pathological variability in that they contained more than one kind of characteristic inclusion body in the neuronal lysosomal storage compartment. In all 19 NCL brains, small amounts of aging lipofuscin were also found.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319116     DOI: 10.1002/ajmg.1320420420

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  14 in total

1.  Juvenile neuronal ceroid lipofuscinosis.

Authors:  S Gulati; R Maheshwari; M Kabra; I C Verma; V Kalra
Journal:  Indian J Pediatr       Date:  2000-09       Impact factor: 1.967

2.  The adult and a new late adult forms of neuronal ceroid lipofuscinosis.

Authors:  J Constantinidis; K E Wisniewski; T M Wisniewski
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  Clinical trials in rare disease: challenges and opportunities.

Authors:  Erika F Augustine; Heather R Adams; Jonathan W Mink
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

4.  Neuronal ceroid lipofuscinosis with prominent accumulation of ceroid lipofuscin in the myocardium.

Authors:  V Jay; R Haslam
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 5.  Adult type of neuronal ceroid-lipofuscinosis.

Authors:  J J Martin
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

6.  Glycoconjugate abnormalities in the ceroid-lipofuscinoses.

Authors:  R K Pullarkat; S E Zawitosky
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

Review 7.  Seizures, depression and dementia in teenagers with Batten disease.

Authors:  R M Boustany; P Filipek
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

8.  Increased urine concentration of subunit c of mitochondrial ATP synthase in neuronal ceroid lipofuscinoses patients.

Authors:  K E Wisniewski; A A Golabek; E Kida
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

9.  Batten disease (ceroid-lipofuscinosis): the enigma of subunit c of mitochondrial ATP synthase accumulation.

Authors:  R D Jolly
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

10.  Accumulation of sphingolipid activator proteins (SAPs) A and D in granular osmiophilic deposits in miniature Schnauzer dogs with ceroid-lipofuscinosis.

Authors:  D N Palmer; J Tyynelä; H C van Mil; V J Westlake; R D Jolly
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.